000 | 01267 a2200313 4500 | ||
---|---|---|---|
005 | 20250517074033.0 | ||
264 | 0 | _c20170711 | |
008 | 201707s 0 0 eng d | ||
022 | _a1618-7601 | ||
024 | 7 |
_a10.1007/s10198-015-0758-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBanerjee, Tannista | |
245 | 0 | 0 |
_aWhy trash don't pass? pharmaceutical licensing and safety performance of drugs. _h[electronic resource] |
260 |
_bThe European journal of health economics : HEPAC : health economics in prevention and care _cJan 2017 |
||
300 |
_a59-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLicensure _xlegislation & jurisprudence |
650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
650 | 0 | 4 | _aSafety-Based Drug Withdrawals |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Food and Drug Administration |
700 | 1 | _aNayak, Arnab | |
773 | 0 |
_tThe European journal of health economics : HEPAC : health economics in prevention and care _gvol. 18 _gno. 1 _gp. 59-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10198-015-0758-x _zAvailable from publisher's website |
999 |
_c25643261 _d25643261 |